The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's nasal spray flu vaccine for ...

AstraZeneca has completed its clinical programme supporting the transition of its respiratory medicine to a low-carbon propellant with considerably lower Global Warming Potential (GWP).

Sanofi said on Monday the U.S. Food and Drug Administration has approved a manufacturing line for its and partner AstraZeneca ...

As this year’s respiratory syncytial virus (RSV) season approaches, Beyfortus makers Sanofi and AstraZeneca are making preparations to avoid last year's supply issue with a newly approved filling l ...

Paid and presented by AstraZeneca. When Cleusa was diagnosed with advanced lung cancer, she needed support attending her appointments in the city. Find out how a respiratory programme is helping ...

Vaccine-preventable respiratory diseases like influenza and pneumococcal disease cost the global community more that 23 million years of life due to premature mortality. Adult vaccines have been ...

Two AstraZeneca (AZ) drugs have been approved in Japan – its cancer drug Lynparza and its respiratory drug Fasenra. The Japanese Ministry of Health, Labour and Welfare approved Lynparza ...

AstraZeneca Plc shares are on track for their biggest weekly decline since July 2023, after a disappointing update for the British drugmaker’s experimental lung cancer medicine with partner ...

Also, Astra is well-positioned in the respiratory and diabetes spaces, but these areas tend to have poor pricing power relative to cancer drugs. In addition to internal development, AstraZeneca ...

In this article, we are going to take a look at where AstraZeneca PLC (NASDAQ:AZN) stands against the other 52-week high stocks. The U.S. stock market has been on a roll, with major indices ...